ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,612,200 | -24.6% | 60,000 | 0.0% | 0.02% | -36.8% |
| Q2 2023 | $2,139,600 | +19.8% | 60,000 | -14.7% | 0.04% | +8.6% |
| Q1 2023 | $1,785,620 | -40.0% | 70,300 | -21.9% | 0.04% | -16.7% |
| Q3 2022 | $2,974,000 | -3.9% | 90,000 | +2.4% | 0.04% | -2.3% |
| Q2 2022 | $3,095,000 | -65.1% | 87,900 | -54.4% | 0.04% | -59.4% |
| Q1 2022 | $8,872,000 | +53.1% | 192,934 | +120.7% | 0.11% | +63.1% |
| Q4 2021 | $5,796,000 | +53.3% | 87,400 | +44.3% | 0.06% | +47.7% |
| Q3 2021 | $3,781,000 | -71.4% | 60,556 | -62.0% | 0.04% | -74.6% |
| Q2 2021 | $13,209,000 | +7.6% | 159,500 | -0.3% | 0.17% | -38.0% |
| Q4 2020 | $12,278,000 | +850.3% | 160,000 | +433.3% | 0.28% | +830.0% |
| Q3 2020 | $1,292,000 | -51.2% | 30,000 | -51.1% | 0.03% | -65.9% |
| Q2 2020 | $2,647,000 | +409.0% | 61,302 | +647.6% | 0.09% | +417.6% |
| Q4 2019 | $520,000 | -69.2% | 8,200 | -86.3% | 0.02% | -80.7% |
| Q3 2019 | $1,690,000 | -36.2% | 60,000 | -40.0% | 0.09% | -33.8% |
| Q2 2019 | $2,649,000 | – | 100,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |